On March 17th, InPrint Munich, an international exhibition of printing technology for industrial manufacturing, hosted the presentation by Dr Achim Weber, deputy head of the Innovation Field Functional Surfaces and Materials of Fraunhofer Institute: “Liquid handling and 3D bioprinting using chemically modified biopolymers“.
Weber took advantage of the context of 3D bioprinting technology to present the European project TriAnkle whose objective is to improve the treatment of all patients suffering from osteoarticular diseases through the development of personalized implants based on collagen and gelatin manufactured with 3D technology. This treatment involves an increase of between 10 and 15% of the recovery rates of the functionality of the ankle joints, as well as a reduction of around 50% in the recovery times of this type of ailments.
Some factors such as the difficulty of directly observing a tendinopathy complicate the patient’s recovery process. Today there are two alternatives offered by medicine to